Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
基本信息
- 批准号:10028851
- 负责人:
- 金额:$ 46.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAdenosine MonophosphateAffectAgeAge related macular degenerationAgingBiogenesisBiological AssayCatalytic DomainCell NucleusCellsDataData AnalysesDefectDevelopmentDiseaseFunctional disorderGene ExpressionGenesGenetic TranscriptionGlucoseGlutamate Metabolism PathwayGlutamineGoalsInheritedKnockout MiceLabelLightLinkMacular degenerationMeasuresMediatingMetabolicMetabolic PathwayMetabolismMetforminMitochondriaMitochondrial DNAMusMutationNuclearPPAR gammaPathway AnalysisPathway interactionsPharmaceutical PreparationsPhosphotransferasesPhotoreceptorsPloidiesPublishingResearchRetinaRetinal DegenerationRetinal PhotoreceptorsRodRoleTestingTherapeuticThinnessTissuesUnited Statesage relatedcofactordesigngain of functiongene functionin vivoinherited retinal degenerationloss of functionmetabolomicsmitochondrial dysfunctionmitochondrial metabolismoxidative damagerepairedresponseretinal neuronsingle-cell RNA sequencingtranscriptome sequencinguptake
项目摘要
Abstract:
The retina has high metabolic activity, and retinal degenerations have been associated with mitochondrial
dysfunction, dysregulation of metabolism, and toxic oxidative damage. However, little is known about how
metabolism is maintained under normal conditions or is dysregulated in degenerating retinas. AMPK (AMP-
activated protein kinase) is a key regulator of metabolism in highly metabolic tissues and is a candidate to
regulate metabolism in photoreceptors, and its role in retinal metabolism will be rigorously studied in this
proposed project using both gain-of-function and loss-of-function approaches. Peroxisome proliferator-activated
receptor gamma coactivator-alpha (PGC-1α) and beta (PGC-1β) are key regulators of mitochondrial biogenesis.
Adenosine monophosphate dependent kinase (AMPK) is an important regulator of PGC-1 activity. Our goal in
this study is to determine the roles of AMPK and PGC-1 activity in retinal photoreceptors.
摘要:
视网膜具有很高的代谢活性,视网膜退化与线粒体有关。
功能障碍、新陈代谢失调和毒性氧化损伤。然而,人们对此知之甚少。
在退化的视网膜中,新陈代谢在正常情况下维持或被失调。AMPK(AMP-
激活的蛋白激酶)是高代谢组织中代谢的关键调节器,是
调节光感受器的代谢,以及它在视网膜新陈代谢中的作用将在本文中进行严格的研究
建议的项目采用功能增益和功能损失两种方法。过氧化物酶体增殖物激活
受体γ-辅活化子-α(pGC-1α)和β(pGC-1β)是线粒体生物发生的关键调控因子。
单磷酸腺苷依赖激酶(AMPK)是PGC-1活性的重要调节因子。我们的目标是
本研究旨在探讨AMPK和PGC-1活性在视网膜光感受器中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John D Ash其他文献
John D Ash的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John D Ash', 18)}}的其他基金
Dual Targeting Mitochondria and GPCR in Retinal Protection
双靶向线粒体和 GPCR 在视网膜保护中的作用
- 批准号:
10383538 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10477262 - 财政年份:2021
- 资助金额:
$ 46.71万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10296291 - 财政年份:2021
- 资助金额:
$ 46.71万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10842755 - 财政年份:2021
- 资助金额:
$ 46.71万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10455542 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10247603 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10834510 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Administrative Supplement to Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜视网膜代谢调节剂的行政补充
- 批准号:
10361928 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Comparative transcriptomic and epigenomic analyses of Muller glia reprogramming
Muller 胶质细胞重编程的比较转录组和表观基因组分析
- 批准号:
9551199 - 财政年份:2016
- 资助金额:
$ 46.71万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 46.71万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 46.71万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
Studentship Programs